Skip to content

Cohort Study on A Following-up System of Native Arteriovenous Fistulae

Cohort Study on A Following-up System of Native Arteriovenous Fistulae in Chinese Patients Treated by Maintenance Hemodialysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02880761
Enrollment
209
Registered
2016-08-26
Start date
2016-07-31
Completion date
2018-09-30
Last updated
2019-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriovenous Fistulae

Keywords

hemodialysis, chronic renal failure, arteriovenous fistulae

Brief summary

A cohort including more than 100 maintenance hemodialysis patients will be followed up according to a certain Following-up System of Native Arteriovenous Fistulae (AVF) prospectively. The assessment results of the Following-up System of AVF help the physicians make decisions of AVF surgery and puncture methods. The results of this study would identify the effect of the system on survival of AVF. Other 100 hemodialysis patients from other centers will be treated by routine protocol and compared to the experiment goup.

Detailed description

The Following-up System of AVF includes 3 stages. In the 1st stage, before AVF surgery operation, the contents of Following-up System of AVF include history, physical exam, ultrasonography detection. The assesment results will guide the methods of the AVF surgery operation. In the 2nd stage, before AVF puncture firstly and 3 months after AVF operation, the contents of Following-up System of AVF include physical exam and ultrasonography detection. The results will help the nurses and doctors make a decision of the method of AVF puncture. In the 3rd stage, during the following 2 years after AVF puncture successfully, the contents include physical exam and ultrasonography detection regularly. The adequacy of hemodialysis by using AVF will be assessed by urea clearance index (Kt/V). The data of patients in other hemodialysis centers will be recorded and compared to the patients in experiment group.

Interventions

PROCEDUREAssessment guiding surgery and puncture for AVF

Assessment guiding surgery and puncture for AVF. Assessing the parameters of vascular vessels during following-up and making suggestions on surgery and puncture of AVF

Sponsors

Peking University International Hospital
CollaboratorOTHER
Capital Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Maintenance hemodialysis patients using AVF; * Ages 18-70 years old; * Agreement with frequent following-up.

Exclusion criteria

* Younger than 18 years or elder than 70 years; * Cachexia; * Acute renal failure; * Exceptive life time less than 6 months; * Pregnant or planning pregnant; * Waiting for renal transplantation or transferring to peritoneal dialysis.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Fistula Failure3 months after surgeryThe AVF can not be used for hemodialysis treatment 3 months after surgery, which it is defined as Primary Failure of AVF. The primary failure of AVF is regarded as the primary outcome of the patients who were followed up. The ratio of primary failure will be compared between two groups.

Secondary

MeasureTime frameDescription
Life Time of AVFEqual to or larger than 2 yearsThe life time of an available AVF since the AVF is functionable. The life time of an AVF is a period time from the AVF used for hemodialysis treatment at first time to the last time when the AVF can not be used for hemodialysis therapy,, whichever came first, assessed up to 48 months. Since the AVF will be punctured in every hemodialysis session, the function of AVF were detected during every treatment session (3 times per week).

Other

MeasureTime frameDescription
Mean Value of Urea Clearance Index During 24 Months2 yearsAs a parameter of hemodialysis adequacy, urea clearance index (Kt/V) will be detected very month. The Kt/V should be larger than 1.2 , which were regarded as being adequate in the hemodialysis session. This parameter will be tested every month and the mean value were be calculated according to the records during 24 months. Those who with Kt/V less than 1.2 for 3 times would be defined as the patient with unfunctional AVF. The values of Kt/V in unfunctional AVF patients would not be used in statistic analysis.

Countries

China

Participant flow

Participants by arm

ArmCount
Intervention
Patients with AVF will be followed up by a preset following-up system. Interventions would be administered according to the assessment for AVF, which including the surgery and puncture of AVF. For AVF surgery, a certain vein would be used in the operation according to the assessment results. For AVF puncture, the methods, such as 'button hole', 'rope ladder', dwelling needle, would be selected prospectively according to the assessment results. Assessment guiding surgery and puncture for AVF: Assessment guiding surgery and puncture for AVF. Assessing the parameters of vascular vessels during following-up and making suggestions on surgery and puncture of AVF
87
Control
Patients in other hemodialysis centers who are treated by routine protocal would be enrolled into control group. Their clinical data would be collected and compared with intervention group.
85
Total172

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyDeath68
Overall StudyLost to Follow-up34
Overall StudyProtocol Violation43
Overall StudyWithdrawal by Subject36

Baseline characteristics

CharacteristicInterventionControlTotal
Age, Continuous55.3 year
STANDARD_DEVIATION 11.9
55.3 year
STANDARD_DEVIATION 12.1
55.3 year
STANDARD_DEVIATION 12
Height(cm)167.3 cm
STANDARD_DEVIATION 7.7
167.4 cm
STANDARD_DEVIATION 7.9
167.3 cm
STANDARD_DEVIATION 7.8
Race/Ethnicity, Customized
Han
87 Participants85 Participants172 Participants
Sex: Female, Male
Female
50 Participants48 Participants98 Participants
Sex: Female, Male
Male
37 Participants37 Participants74 Participants
Weight(Kg)67.0 Kg
STANDARD_DEVIATION 12.5
66.6 Kg
STANDARD_DEVIATION 10.7
66.8 Kg
STANDARD_DEVIATION 11.1

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
6 / 1038 / 106
other
Total, other adverse events
2 / 1031 / 106
serious
Total, serious adverse events
4 / 1036 / 106

Outcome results

Primary

Number of Participants With Fistula Failure

The AVF can not be used for hemodialysis treatment 3 months after surgery, which it is defined as Primary Failure of AVF. The primary failure of AVF is regarded as the primary outcome of the patients who were followed up. The ratio of primary failure will be compared between two groups.

Time frame: 3 months after surgery

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
InterventionNumber of Participants With Fistula Failure11 Participants
ControlNumber of Participants With Fistula Failure15 Participants
Secondary

Life Time of AVF

The life time of an available AVF since the AVF is functionable. The life time of an AVF is a period time from the AVF used for hemodialysis treatment at first time to the last time when the AVF can not be used for hemodialysis therapy,, whichever came first, assessed up to 48 months. Since the AVF will be punctured in every hemodialysis session, the function of AVF were detected during every treatment session (3 times per week).

Time frame: Equal to or larger than 2 years

ArmMeasureValue (MEAN)Dispersion
InterventionLife Time of AVF30.5 monthStandard Deviation 21.6
ControlLife Time of AVF26.8 monthStandard Deviation 19.9
Other Pre-specified

Mean Value of Urea Clearance Index During 24 Months

As a parameter of hemodialysis adequacy, urea clearance index (Kt/V) will be detected very month. The Kt/V should be larger than 1.2 , which were regarded as being adequate in the hemodialysis session. This parameter will be tested every month and the mean value were be calculated according to the records during 24 months. Those who with Kt/V less than 1.2 for 3 times would be defined as the patient with unfunctional AVF. The values of Kt/V in unfunctional AVF patients would not be used in statistic analysis.

Time frame: 2 years

ArmMeasureValue (MEAN)Dispersion
InterventionMean Value of Urea Clearance Index During 24 Months1.31 Kt/VStandard Deviation 0.28
ControlMean Value of Urea Clearance Index During 24 Months1.29 Kt/VStandard Deviation 0.27

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026